Skip to content

Postoperative Patient-controlled Perineural Analgesia After Orthopedic Surgery by Remote Control Versus Bedside Care

Postoperative Patient-controlled Perineural Analgesia After Orthopedic Surgery: A Medico-economic Comparative Evaluation of Patient Management by Remote Control Versus Bedside Care

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02018068
Acronym
MICREL
Enrollment
72
Registered
2013-12-23
Start date
2014-01-14
Completion date
2016-07-27
Last updated
2018-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Injury of Foot, Shoulder or Knee, Pain, Postoperative, Perineural Analgesia

Keywords

Patient-controlled Perineural analgesia, Postoperative, Orthopedic surgery, Remote Control versus at bedside care, Comparative medico-economic evaluation

Brief summary

Perineural injection of local anesthesic is currently the reference method for the treatment of post operative pain in a patient undergoing major orthopedic surgery. Postoperative pain is a dynamic phenomena in every patient. It is classified as intense during the first postoperative hours after surgery, and decreases in a non-linear manner over the days following the procedure. PCA (patient control analgesia) infusion of local anesthesic allows an adaptation of the local analgesia doses to the evaluated pain scores, as well as permit a decrease in adverse events related to the continuous infusion technique (motor or sensory blockade, paresthesia, etc.). The physician can also modify the pump settings according to the postoperative rehabilitation plan.The use of new communication techniques such as telemedecine may be of interest in reducing treatment onset time and optimizing pain management. The remote control consists to change the settings of the pump after if the anesthesiologist was informed in real time (via a smartphone or a tablet) on patient pain level, sensory and motor blockades. The physician goes to a dedicated website (Micrel CareTM). and makes the necessary changes by remote control via a GPRS (General Packet Radio Service) connexion. The aim of this prospective, comparative, multicentric trial is to compare the effectiveness of patient management through two communication modalities: remote control versus bedside care.

Interventions

OTHERRemote control

When pain or sensory and motor block evaluation exceed the thresholds, the patient enters the data in the PCA (patient Control Analgesia) pump. The investigator is alerted by SMS on his smartphone and makes the necessary programming changes by remote control on the Micrel Care TM site. Systematic assessments via the PCA pump are scheduled for 9:00, 13:00 and 19:00 every day during 48 to 72 hours. The patient can alert his physician through his PCA pump of any additional requests (pain, motor blockade, numbness). The anesthesiologist receives an SMS alert and can make any necessary programming changes to the pump via the remote control.

OTHERAt bedside care

When pain or sensory and motor block evaluation exceed the thresholds, the nurse contacts the physician and she will be able to modify the pump settings according to the anesthesiologist prescription. The delay between the call of the patient and the programming changes, the duration of the procedure are reported. Systematic evaluations via the PCA (Patient Control Analgesia) pump are done when the patient arrives in this surgical ward and at 9:00, 13:00 and 19:00 every day for 48 to 72 hours.Throughout the study, if necessary, the nurse or referring physician performs the programming changes directly on the PCA pump and notes the delay in treatment. All the reasons and the duration of any bedside visit are reported.

Sponsors

University Hospital, Montpellier
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients scheduled for elective orthopedic surgery * Patients older than 18 years old * Patient with a surgical indication (foot, shoulder or knee) which can require placement of a perineural catheter * Patients classified ASA class I to III * Informed consent

Exclusion criteria

* Contraindication to regional anesthesia or local anesthetics * Contraindication to paracetamol, ketoprofen or morphine (depending on the selected rescue analgesia) * Hospital discharge less than 48 hours after surgery * Psychomotor disease (teletransmission contraindication) * Patient undergoing surgery with a duration greater than 4 hours * Patient with a duration of perineural catheter less than 48 hours * Protected patient * Patient enrolled in another study * Patient who can't understand local language

Design outcomes

Primary

MeasureTime frame
Time between the patient's call and the change in Patient Control Analgesia (PCA) pump settingsfrom arriving at the ward after surgery until 72 postoperative hours

Secondary

MeasureTime frame
Duration of nursing interventionsfrom arriving at the ward after surgery until 72 postoperative hours
Post operative pain measured by VAS (Visual Analog Scale)from before implementation of PCA until 72 postoperative hours
Amount of rescue analgesiafrom implementation of PCA (Patient Control Analgesia) until 72 postoperative hours
Patient satisfaction Score at catheter removal (at 72 postoperative hours)at 72 postoperative hours
Number of nursing interventionsfrom arriving at the ward after surgery until 72 postoperative hours
the physiotherapist's satisfaction scoresat 72 postoperative hours
Healthcare staff (nurse and physician) satisfaction scoresat 72 postoperative hours
Duration of hospital stayAt the end of hospital stay (an expected average of 72 postoperative hours)
Overall cost of patient management strategyuntil end of postoperative patient management (an average of 72 postoperative hours)
Time until the start of physical therapyfrom surgery until 72 postoperative hours

Countries

France, Netherlands, United Arab Emirates

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026